Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity.
PHARMACEUTICAL RESEARCH（2023）
Key words
drug-drug interaction,endogenous biomarker,ritlecitinib,rosuvastatin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined